5 Results for "

Netherton syndrome

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "Netherton syndrome" in MCE Product Catalog:

Cat. No.: HY-148949A
Purity:  99.53%
Target:  

Kallikrein

Research Areas:  

Others

Kallikrein 5-IN-2 TFA is the TFA salt form of Kallikrein 5-IN-2 (HY-148949). Kallikrein 5-IN-2 TFA is a selective inhibitor for kallikrein 5 (KLK5) with pIC50 of 7.1. Kallikrein 5-IN-2 TFA is non-phototoxic (100 μg/mL) and non-irritant. Kallikrein 5-IN-2 is stable at pH 4-pH 8 under non-oxidative condition. Kallikrein 5-IN-2 is potent in ameliorating the Netherton syndrome .
loading...
    loading...
Cat. No.: HY-P4669
CAS No.: 1122484-55-2
Synonyms: BPR277
Target:  

Kallikrein Elastase

Research Areas:  

Inflammation/Immunology

LM-030 (BPR277), cyclic depsipeptide, is a potent kallikrein-related peptidase 7 (KLK7) and human neutrophil elastase inhibitor with IC50 values of 1 and 10 nM. LM-030 can be used for the study of Netherton syndrome .
loading...
    loading...
Cat. No.: HY-150085
CAS No.: 2393881-77-9
Target:  

Kallikrein

Research Areas:  

Inflammation/Immunology

GSK951 is a highly potent, selective, and reversibly covalent KLK5 inhibitor, with an IC50 of approximately 250 pM and a pIC50 of 9.6 against hKLK5. It exhibits over 100-fold selectivity over KLK7, KLK14, matriptase, and elastase. GSK951 binds to the catalytic site of KLK5 via covalent interaction with the catalytic serine, with a slow dissociation rate. GSK951 improves skin barrier function, reduces transepidermal water loss, decreases the expression of proinflammatory cytokines, and inhibits the elevated KLK5 protease activity in the stratum corneum. GSK951 can be used in studies related to skin barrier dysfunction.
loading...
    loading...
Cat. No.: HY-P11840
KLK5-IN-1 is a selective kallikrein 5 (KLK5) inhibitor with an IC50 of 14 nM and a Ki of 11 nM. KLK5-IN-1 reduces KLK5-mediated PAR2-dependent calcium mobilization. KLK5-IN-1 improves epithelial barrier integrity. KLK5-IN-1 can be used in research related to atopic dermatitis and Netherton syndrome .
loading...
    loading...
Cat. No.: HY-100497
CAS No.: 1087624-28-9
Target:  

Kallikrein

Research Areas:  

Inflammation/Immunology

KLK5/14-IN-1 is a selective human skin kallikrein inhibitor with IC50 values of 0.048 μM, 0.2 μM, and 0.1 μM for KLK7, KLK5, and KLK14, respectively. KLK5/14-IN-1 shows no or only low inhibitory activity against Cathepsin G, Chymotrypsin, Trypsin, and Thrombin. KLK5/14-IN-1 can be used in research related to Netherton syndrome .
loading...
    loading...